Search by Drug Name or NDC
NDC 59467-0700-27 Ryaltris 25; 665 ug/1; ug/1 Details
Ryaltris 25; 665 ug/1; ug/1
Ryaltris is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by HIKMA SPECIALTY USA INC.. The primary component is MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE.
Product Information
| NDC | 59467-0700 |
|---|---|
| Product ID | 59467-700_d6cac74c-1bfc-4745-8a35-27f03686c86c |
| Associated GPIs | |
| GCN Sequence Number | 081937 |
| GCN Sequence Number Description | olopatadine HCl/mometasone SPRAY/PUMP 665-25 MCG NASAL |
| HIC3 | Q7O |
| HIC3 Description | NASAL ANTIHISTAMINE AND ANTI-INFLAM. STEROID COMB. |
| GCN | 49205 |
| HICL Sequence Number | 047115 |
| HICL Sequence Number Description | OLOPATADINE HCL/MOMETASONE FUROATE |
| Brand/Generic | Brand |
| Proprietary Name | Ryaltris |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | olopatadine hydrochloride and mometasone furoate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 25; 665 |
| Active Ingredient Units | ug/1; ug/1 |
| Substance Name | MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE |
| Labeler Name | HIKMA SPECIALTY USA INC. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor In |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211746 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59467-0700-27 (59467070027)
| NDC Package Code | 59467-700-27 |
|---|---|
| Billing NDC | 59467070027 |
| Package | 12 CARTON in 1 BOX (59467-700-27) / 1 BOTTLE, SPRAY in 1 CARTON / 240 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Marketing Start Date | 2022-08-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8.23132 |
| Pricing Unit | GM |
| Effective Date | 2023-09-20 |
| NDC Description | RYALTRIS 665-25 MCG SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis